Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Ebiomedicine|September 27, 2025
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trialLisanne A H Bevers, Gabriela Toledo, Muzamil Kisekka, et al.
Contemporary Clinical Trials|April 18, 2024
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 yearsAnna Turkova, Man K Chan, Cissy Kityo, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
Journal of the International AIDS Society|September 28, 2023
Effect of dolutegravir on folate, vitamin B12 and mean corpuscular volume levels among children and adolescents with HIV: a sub-study of the ODYSSEY randomized controlled trialLinda Namutebi Barlow-Mosha, Grace Miriam Ahimbisibwe, Elizabeth Chappell, et al.
The Journal of Infectious Diseases|March 27, 2012
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panelStephen M Graham, Tahmeed Ahmed, Farhana Amanullah, et al.
Trials|April 5, 2022
The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trialRonnie Kasirye, Heather A Hume, Evan M Bloch, et al.
Lancet (London, England)|July 29, 2008
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials, Abubaker Bedri, Berhanu Gudetta, et al.
The American Journal of Tropical Medicine and Hygiene|December 29, 2020
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research CollaborationJean B Nachega, Nadia A Sam-Agudu, Samantha Budhram, et al.
Transfusion|May 31, 2023
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022Evan M Bloch, Dorothy Kyeyune, Jodie L White, et al.
The New England Journal of Medicine|December 29, 2021
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in ChildrenAnna Turkova, Ellen White, Hilda A Mujuru, et al.
Pageof 17